Evidence that Non-Fibrillar Tau Causes Pathology Linked to Neurodegeneration and Behavioral Impairments
- 24 July 2008
- journal article
- review article
- Published by IOS Press in Journal of Alzheimer's Disease
- Vol. 14 (4), 393-399
- https://doi.org/10.3233/jad-2008-14406
Abstract
The discovery that mutations within the tau gene lead to frontotemporal dementia with Parkinsonism linked to chromosome 17 (FTDP-17) provided direct evidence that tau alterations can lead to neurodegenerative disease. While the presence of tau fibrilKeywords
This publication has 57 references indexed in Scilit:
- Granular Tau Oligomers as Intermediates of Tau FilamentsBiochemistry, 2007
- Characterization of paired helical filaments by scanning transmission electron microscopyMicroscopy Research and Technique, 2005
- Microtubule-binding drugs offset tau sequestration by stabilizing microtubules and reversing fast axonal transport deficits in a tauopathy modelProceedings of the National Academy of Sciences, 2004
- Mutations causing neurodegenerative tauopathiesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2004
- Tau-Mediated Cytotoxicity in a Pseudohyperphosphorylation Model of Alzheimer's DiseaseJournal of Neuroscience, 2002
- Accelerated filament formation from tau protein with specific FTDP‐17 missense mutationsFEBS Letters, 1999
- Domains of tau protein, differential phosphorylation, and dynamic instability of microtubules.Molecular Biology of the Cell, 1995
- Structure and novel exons of the human .tau. geneBiochemistry, 1992
- Distribution of Alzheimer‐type pathologic changes in nondemented elderly individuals matches the pattern in Alzheimer's diseaseNeurology, 1992
- Multiple isoforms of human microtubule-associated protein tau: sequences and localization in neurofibrillary tangles of Alzheimer's diseaseNeuron, 1989